Literature DB >> 8798720

SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.

K Colwill1, L L Feng, J M Yeakley, G D Gish, J F Cáceres, T Pawson, X D Fu.   

Abstract

Serine/arginine-rich (SR) proteins are essential for pre-mRNA splicing, and modify the choice of splice site during alternative splicing in a process apparently regulated by protein phosphorylation. Two protein kinases have been cloned that can phosphorylate SR proteins in vitro: SRPK1 and Clk/Sty. Here, we show that these two kinases phosphorylate the same SR proteins in vitro, but that SRPK1 has the higher specific activity toward ASF/SF2. SRPK1, like Clk/Sty, phosphorylates ASF/SF2 in vitro on sites that are also phosphorylated in vivo. Tryptic peptide mapping of ASF/SF2 revealed that three of the phosphopeptides from full-length ASF/SF2 phosphorylated in vitro contain consecutive phosphoserine-arginine residues or phosphoserine-proline residues. In vitro, the Clk/Sty kinase phosphorylated Ser-Arg, Ser-Lys, or Ser-Pro sites, whereas SRPK1 had a strong preference for Ser-Arg sites. These results suggest that SRPK1 and Clk/Sty may play different roles in regulating SR splicing factors, and suggest that Clk/Sty has a broader substrate specificity than SRPK1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798720     DOI: 10.1074/jbc.271.40.24569

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  86 in total

1.  Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.

Authors:  M Molin; G Akusjärvi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Alternative splicing modulation by a LAMMER kinase impinges on developmental and transcriptome expression.

Authors:  Sigal Savaldi-Goldstein; Dvora Aviv; Olga Davydov; Robert Fluhr
Journal:  Plant Cell       Date:  2003-04       Impact factor: 11.277

3.  Sequential entry of components of the gene expression machinery into daughter nuclei.

Authors:  Kannanganattu V Prasanth; Paula A Sacco-Bubulya; Supriya G Prasanth; David L Spector
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

4.  Multiple roles for SR proteins in trans splicing.

Authors:  Suzanne Furuyama; James P Bruzik
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 5.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

6.  Multiple properties of the splicing repressor SRp38 distinguish it from typical SR proteins.

Authors:  Chanseok Shin; Frida E Kleiman; James L Manley
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Phosphorylation by SR kinases regulates the binding of PTB-associated splicing factor (PSF) to the pre-mRNA polypyrimidine tract.

Authors:  Ching-Jung Huang; Zhaohua Tang; Ren-Jang Lin; Philip W Tucker
Journal:  FEBS Lett       Date:  2006-12-14       Impact factor: 4.124

8.  The role of the Drosophila LAMMER protein kinase DOA in somatic sex determination.

Authors:  Leonard Rabinow; Marie-Laure Samson
Journal:  J Genet       Date:  2010-09       Impact factor: 1.166

Review 9.  Substrate and docking interactions in serine/threonine protein kinases.

Authors:  Elizabeth J Goldsmith; Radha Akella; Xiaoshan Min; Tianjun Zhou; John M Humphreys
Journal:  Chem Rev       Date:  2007-10-19       Impact factor: 60.622

Review 10.  Therapeutic potential of manipulating VEGF splice isoforms in oncology.

Authors:  Emma S Rennel; Steven J Harper; David O Bates
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.